Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (Fv-IgG) (CAT#: BSDG-073)
Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD3 IgG with similar domains from an anti-CLEC12A antibody via short peptide linkers, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Myelodysplastic syndromes (MDS); Chronic myelogenous leukemia (CML) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (Fv-IgG) (BSDG-073). Click the button below to contact us or submit your feedback about this product.